Liminal BioSciences Inc. LMNL

Healthcare Biotechnology

Liminal BioSciences is a biopharmaceutical company focused on the discovery and development of novel, small molecule drug candidates for the treatment of patients suffering from fibrotic or inflammatory diseases that have a high unmet medical need. Liminal BioSciences operates on an integrated basis from our talent hubs in Laval, Quebec, Canada, and Cambridge, UK. Our common shares are listed for trading on the Nasdaq Global Market.

NDAQ:LMNL - Post by User

Liminal BioSciences Inc. > bought some here below 3$

<< Previous

Bullboard Posts

Next >>

Comment by Arrakis37on Aug 10, 2021 1:16pm

32 Views

Post# 33678802

RE:bought some here below 3$

LMAO

Hey ! How do you spell Ryplazim ?

LOL

Mariadelapena wrote: Look how much money we're getting from voucher (nr 100M$) + Look at market cap (around 100M$ as well)

I agree this is big news that analysts will pick up next days + now that LMNL has major cash, they will soon announce what indications they will pursue on their pipeline,

price targets will move up as well...i do think buying here makes sense. LMNL is now well financed